Hepatitis C: Know Your Status

Published Online: Friday, February 24, 2012
Follow Pharmacy_Times:
Approximately 4 million people in the United States have hepatitis C. Many do not have any symptoms, so those who have risk factors for the disease should get tested. Symptoms, when they do appear, include itchiness, confusion, swelling of the belly and feet, and jaundice of the eyes and skin. Once these symptoms appear, serious damage may already have been done to the liver. The disease is curable, however, so if a patient tests positive, he or she can work with a doctor to map out a treatment plan.
 
To learn more, check out this video:

Related Articles
The FDA today approved ombitasvir, paritaprevir, and ritonavir tablets copackaged with dasabuvir tablets to treat individuals with chronic hepatitis C virus genotype 1 infection, including patients with cirrhosis.
The Bristol-Myers Squibb Foundation today announced nine new grants totaling more than $3.5 million to strengthen efforts in China and India in the fight against hepatitis B virus and hepatitis C virus infection by focusing on the most vulnerable, high-risk patient populations.
A study from Merck has demonstrated high response to grazoprevir/elbasvir with and without ribavirin across various hepatitis C virus populations, including difficult-to-cure patients.
Gilead Sciences Inc. has reported positive results from its phase 2 and phase 3 studies on ledipasvir 90 mg/sofosbuvir 400 mg in patients with chronic hepatitis C virus.
Latest Issues
$auto_registration$